JWM
NAGE

JPL Wealth Management’s Niagen Bioscience NAGE Stock Holding History

JPL Wealth Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16 Sell
5
-28
-85% -$114 ﹤0.01% 1813
2026
Q1 		$146 Buy
+33
New +$178 ﹤0.01% 1443

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JPL Wealth Management's NAGE Position: Q2 2026 in Review

JPL Wealth Management reduced its Niagen Bioscience (NAGE) stake by 85% in Q2 2026, selling an estimated $114 and leaving 5 shares worth $16. The position accounts for ﹤0.01% of the portfolio, ranked #1813.

JPL Wealth Management first reported a position in NAGE in Q1 2026 and has held it in 2 quarters since. The position peaked at $146 in Q1 2026. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • JPL Wealth Management held 5 shares of Niagen Bioscience worth $16 as of Q2 2026.
  • JPL Wealth Management sold 28 Niagen Bioscience shares in Q2 2026, an estimated $114.
  • Niagen Bioscience made up ﹤0.01% of JPL Wealth Management's portfolio in Q2 2026, its #1813 holding.
  • JPL Wealth Management first reported a position in Niagen Bioscience in Q1 2026 and has held it in 2 quarters since.
  • JPL Wealth Management's Niagen Bioscience position peaked at $146 in Q1 2026.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on JPL Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.